Popular Articles

What Is Mental Health? What Is Mental Disorder?
Mental health refers to our cognitive, and/or emotional wellbeing - it is all about how we think, feel and behave. Mental health, if somebody has it, can also mean an absence of a mental disorder. Approximately 25% of people in the UK have a mental health problem during their lives. The USA is said to have the highest incidence of people diagnosed with mental health problems in the developed world. Your mental health can affect your daily life, relationships and even your physical health. Mental health also includes a person"s ability to enjoy life - to attain a balance between life activities and efforts to achieve psychological resilience.
generic viagra online
Aetna Encourages Parents To Consider Their Student's Health Insurance Options When Preparing For College
For parents, summer is the ideal time to ensure college students are prepared academically and financially for campus life. From selecting courses to buying textbooks, there are a number of decisions to be made; however, one important decision - health insurance - is often overlooked. As part of the college preparation process, Aetna (NYSE: AET) encourages parents to also consider their student"s health insurance options before heading off to school.
News of the day
IPS Examines Need For New Drugs To Treat Neglected Tropical Diseases
Inter Press Service News Agency examines the shortcomings of treatments for neglected tropical diseases - which, according to the Drugs for Neglected Diseases Initiative (DNDi), account "for 12 percent of the global disease burden," and 1.3 percent of the new drugs developed between 1975 to 2004. "The diseases in question account for the deaths of 500,000 people annually, mostly in sub-Saharan Africa, but drug development is biased towards the prospect of high profits, which diseases of the poor like sleeping sickness and visceral leishmaniaisis are unable to offer," IPS writes.
Nutrition

Role Of Liver Transplantation Techniques In Surgical Management Of Advanced Renal Urothelial Carcinoma With/without Inferior Vena Cava Thrombus

UroToday.com - Large urothelial carcinoma of the renal pelvis poses a diagnostic as well as surgical challenge to the urologist. This type of malignancy is frequently mistaken preoperatively for renal cell cancer due to its low incidence (10% of all renal malignancies) especially when associated with tumor extension into the inferior vena cava. The presence of a large renal mass should therefore not dissuade the urologist to perform cystoscopy and cytology in order to complete hematuria work-up. Opening the specimen in the operating room will provide clues for the origin of the tumor. The surgical management of large urothelial carcinoma of the renal pelvis is radical nephro-ureterectomy, which may be considerably impeded by major desmoplastic reaction and rich collateralization. Particularly in cases of inferior vena cava involvement liver mobilization is required to achieve complete tumor resection. The department of urology and division of transplantation surgery at University of Miami Miller School of Medicine have collaborated for over 10 years on cases of renal tumors where liver mobilization and inferior vena cava exploration is anticipated. Dr. Gaetano Ciancio bridges the two specialties having completed a urology residency and transplant fellowship at University of Miami. His unique interface allowed the use of liver transplantation techniques for the resection of large renal tumors with or without inferior vena cava involvement. While operative times (mean 7.5 hours) and blood loss (mean 1.5 L) were significant in our series, the tumor could be completely and safely resected in all patients. Nevertheless, mean postoperative survival was only 6 months secondary to disease recurrence. Neoadjuvant chemotherapy may significantly improve survival in such patients as shown previously for muscle-invasive urothelial carcinoma of the bladder, however, it relies on accurate preoperative diagnosis. A prospective clinical trial is needed to evaluate the impact of neoadjuvant chemotherapy on respectability and disease-specific survival. Written by Wolfgang H. Cerwinka, MD1, Murugesan Manoharan, MD, Mark S. Soloway, MD, and Gaetano Ciancio, MD as part of Beyond the Abstract on UroToday.com. UroToday - the only urology website with original content written by global urology key opinion leaders actively engaged in clinical practice. To access the latest urology news releases from UroToday, go to: www.urotoday.com Copyright © 2009 - UroToday


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):